Inventor
JONES GORDON H
US28 patents
⚠️ This page may combine multiple inventors who share the name “JONES GORDON H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNTEX INC
27 patentsUS5545412AAug 13, 1996
N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
SYNTEX INC161 citations99
US5208036AMay 4, 1993
N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
SYNTEX INC406 citations99
US5049386ASep 17, 1991
N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
SYNTEX INC722 citations99
US4946787AAug 7, 1990
N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
SYNTEX INC880 citations99
US4897355AJan 30, 1990
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
SYNTEX INC1,854 citations99
US5550289AAug 27, 1996
N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor
SYNTEX INC58 citations96
US5366737ANov 22, 1994
N-[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N,-tetrasubstituted ammonium lipids and uses therefor
SYNTEX INC36 citations96
US4234571ANov 18, 1980
Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
SYNTEX INC88 citations96
US4082735AApr 4, 1978
Novel immunological adjuvant compounds and methods of preparation thereof
SYNTEX INC71 citations95
US4082736AApr 4, 1978
Novel immunological adjuvant compounds and methods of preparation thereof
SYNTEX INC78 citations95
US5622712AApr 22, 1997
N-[ω, (ω-1)-dialkyloxy]- and N-[ω, (ω-1)-dialkenyloxy]-alk-1-yl-N, N, N-tetrasubstituted ammonium lipids and uses therefor
SYNTEX INC21 citations92
US4490371ADec 25, 1984
N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
SYNTEX INC34 citations92
US4341767AJul 27, 1982
Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
SYNTEX INC41 citations92
US4663320AMay 5, 1987
(2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
SYNTEX INC22 citations81
US4593120AJun 3, 1986
Naphthalene anti-psoriatic agents
SYNTEX INC7 citations74
US4466981AAug 21, 1984
Naphthalene anti-psoriatic agents
SYNTEX INC14 citations74
US4419368ADec 6, 1983
Naphthoquinone anti-psoriatic agents
SYNTEX INC15 citations74
US4318905AMar 9, 1982
Nonapeptide and decapeptide agonists of luteinizing hormone releasing hormone containing heterocyclic amino acid residues
SYNTEX INC17 citations74
US4229478AOct 21, 1980
Naphthaquinone anti-psoriatic agents
SYNTEX INC18 citations74
US4320118AMar 16, 1982
Deca-, undeca-, dodeca- and tridecapeptides with thymic activity
SYNTEX INC18 citations70
US4442127AApr 10, 1984
Naphthoquinone anti-psoriatic agents
SYNTEX INC2 citations63
US4419347ADec 6, 1983
Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
SYNTEX INC5 citations63
US4255405AMar 10, 1981
Naphthoquinone anti-psoriatic agents
SYNTEX INC4 citations63
US4551459ANov 5, 1985
Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-b]quinazolinyl)oxyalkylamides
SYNTEX INC4 citations62
US3935184AJan 27, 1976
Synthetic polyoxin type nucleosides
SYNTEX INC5 citations60
US4840965AJun 20, 1989
Naphthalene anti-psoriatic agents
SYNTEX INC1 citations52
US5091558AFeb 25, 1992
Naphthalene anti-psoriatic agents
SYNTEX INC0 citations42